Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.
Join the news democracy
Where your votes
decide the Top 100
A pioneering treatment that edits healthy immune cells to fight cancer has shown promise for adults and children with a rare and aggressive form of leukaemia that “seemed incurable”.
Almost two thirds of patients with T-cell acute lymphoblastic leukaemia (T-ALL) involved in a clinical trial of the treatment – known as BE-CAR7 – now remain disease-free.
Seven out of 11 patients with incurable cancer who had the treatment appear to be cancer-free.
After embarking on a trial of CAR T-cell therapy, actor Sam Neill announced he is cancer-free. Researchers are enthusiastic the…
Uno studio sul New England Journal of Medicine porta nuove speranze per la terapia contro la leucemia aggressiva di tipologia…
Una terapia di nuova generazione a base di cellule immunitarie modificate (Car-T) ha dato risultati promettenti contro una forma…
Pioneering drug can halt advance of multiple myeloma for three times as long as standard treatments
Fino a pochi anni fa sembrava fantascienza: riprogrammare le cellule del sistema immunitario per trasformarle in armi mirate…
